Skip to main menu Skip to main content Skip to footer
Request Appointment
Contact Us
(303) 730-0404
Make a Payment

Research Program

Clinical Research News - Clinical Trials to the Clinic

Did you know that Colorado Eye Consultants has a robust clinical research department? Our research department partners with pharmaceutical companies to test cutting edge therapies for a wide range of ophthalmic disorders and diseases. With the help and participation of our patients, we can submit the needed data to the pharmaceutical companies to advance these therapies for approval for public use.

Our current research studies include:

Corneal Collagen Crosslinking – EpiOn

Intended for patients with thinning corneal conditions such as keratoconus. This treatment is intended to strengthen and stop the thinning of the cornea, thereby helping to keep vision from deteriorating.  

Persistent Corneal Epithelial Defect – KALA

The purpose of this study is to evaluate the safety and efficacy of a specialized ophthalmic solution in participants with Persistent Corneal Epithelial Defect.

Pterygium – Cloudbreak

Intended to evaluate the safety and efficiency of an emulsion dosed treatment twice daily to reduce conjunctival hyperemia and preventing pterygium progression in the eyes with pterygia.

If you are interested in participating in our studies, please ask our Research Team for more details!

Get In touch


Colorado Eye Consultants is dedicated to the preservation of sight and providing patients with the quality of life they deserve. Our patients receive personalized care by knowledgeable and experienced board certified ophthalmologists to ensure the clarity needed to see the most important things in their world. Your vision is our utmost priority and we offer same day appointments to ensure you get the care you deserve!

Request an Appointment
WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.